We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Psoriasis in Norway: a prescription-based registry study of psoriasis-associated comorbidities

    Background

    Psoriasis is an inflammatory skin disease, frequently associated with comorbidities.

    Objectives

    To characterize comorbidities associated...

    Silje Michelsen Solberg in European Journal of Dermatology
    Article 01 November 2023
  2. Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis

    Psoriasis is associated with various comorbidities with a notable psychosocial burden. This systematic literature review explores the burden of...

    Paula C. Luna, Chia-Yu Chu, ... James Wee in Dermatology and Therapy
    Article Open access 23 November 2023
  3. From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis

    Purpose of Review

    This review summarizes the literature about the transition from psoriasis to psoriatic arthritis (PsA), focusing on musculoskeletal...

    A. L. Ribeiro, L. Eder in Current Rheumatology Reports
    Article 21 March 2024
  4. Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States

    Introduction

    A survey was conducted by The Harris Poll on behalf of Arcutis Biotherapeutics in the USA to understand perspectives and burden of...

    Teri Greiling, Melodie Young, ... April Armstrong in Dermatology and Therapy
    Article Open access 14 June 2024
  5. Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis

    Introduction

    Plaque psoriasis is a chronic condition that may impact patients’ work productivity. Tildrakizumab, an interleukin-23 p19 inhibitor, is...

    Tina Bhutani, John Koo, ... J. Gabriel Vasquez in Dermatology and Therapy
    Article Open access 04 April 2024
  6. Signaling pathways and targeted therapies for psoriasis

    Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on individuals, health systems, and society worldwide. With the...

    Jia Guo, Hanyi Zhang, ... **ang Chen in Signal Transduction and Targeted Therapy
    Article Open access 27 November 2023
  7. Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation

    Background

    Poor sleep quality occurs in patients with psoriasis at rates nearly twice that of the general population. Chronic sleep impairment is an...

    Riley K. Spencer, Joy Q. **, ... Tina Bhutani in Dermatology and Therapy
    Article Open access 05 October 2023
  8. Antistreptococcal treatment of psoriasis: a systematic review

    Streptococcal infections may contribute to psoriasis development, and antistreptococcal treatments are considered potential therapies, but their...

    Beau Sitton, Trent Walker, ... Jessica Kaffenberger in Archives of Dermatological Research
    Article Open access 08 June 2024
  9. Predictors of Psoriasis Area and Severity Index 100 response in Korean patients with moderate-to-severe plaque psoriasis receiving biologics

    Background

    The Psoriasis Area and Severity Index (PASI) 100 response rate after treatment with biologics is reportedly lower in Asians than...

    Tae-Rim Kim, Yumi Won, ... Byungsoo Kim in European Journal of Dermatology
    Article 01 September 2023
  10. Biologic Therapy for Psoriasis Cutting Edge Treatment Principles

    Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder...

    Nicholas Brownstone, Tina Bhutani, Wilson Liao in Updates in Clinical Dermatology
    Book 2022
  11. Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO

    Introduction

    Nail psoriasis is highly prevalent among patients with psoriasis yet remains one of the most challenging areas to treat. To better...

    Elisabeth Riedl, Andreas Pinter, ... Christopher Schuster in Dermatology and Therapy
    Article Open access 22 April 2024
  12. Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents

    New advancements in medicine have paved the way for targeted therapies and immune checkpoint inhibitors (ICIs), which have become mainstays of cancer...

    Vrinda Madan, Laura I. Ortiz-López, ... Vinod E. Nambudiri in Dermatology and Therapy
    Article Open access 22 June 2024
  13. The Immunology of Psoriasis—Current Concepts in Pathogenesis

    Psoriasis is one of the most common inflammatory skin diseases with a chronic, relapsing-remitting course. The last decades of intense research...

    Izabela Sieminska, Monika Pieniawska, Tomasz M. Grzywa in Clinical Reviews in Allergy & Immunology
    Article Open access 20 April 2024
  14. Telemedicine in Nail Psoriasis: Validation of a New Tool to Monitor (In-Person, In-Picture, and In-Video) Nail Psoriasis Severity in Patients with Concurrent Onychophagia and Onychotillomania

    Introduction

    Since during the COVID-19 pandemic nail psoriasis was evaluated exclusively with teledermatology, dermatologists started to face the...

    Alessia Pacifico, Matilde Iorizzo, ... Giovanni Damiani in Dermatology and Therapy
    Article Open access 03 May 2024
  15. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

    Nail psoriasis is a difficult-to-treat manifestation of psoriatic disease affecting up to 80% of patients with psoriatic arthritis (PsA) and 40–60%...

    Bruce W. Kirkham, Alexander Egeberg, ... Luis Puig in Rheumatology and Therapy
    Article Open access 03 July 2023
  16. Psoriasis im Kindes- und Jugendalter

    Psoriasis is nowadays regarded as a multifactorial, inflammatory, immune-mediated systemic condition with predominant involvement of the skin. It...

    Henning Hamm, Peter H. Höger in Monatsschrift Kinderheilkunde
    Article 12 April 2023
  17. Management of Psoriasis Patients with Serious Infectious Diseases

    The management of patients affected by moderate-to-severe psoriasis may be challenging, in particular in patients with serious infectious diseases...

    Matteo Megna, Giuseppe Lauletta, ... Luca Potestio in Advances in Therapy
    Article Open access 06 May 2024
  18. Psoriasis im Kindes- und Jugendalter

    Psoriasis is nowadays regarded as a multifactorial, inflammatory, immune-mediated systemic condition with predominant involvement of the skin. It...

    Henning Hamm, Peter H. Höger in Die Dermatologie
    Article 28 March 2023
  19. Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry

    Introduction

    Near-complete skin clearance has become a rapidly achievable treatment goal for patients with psoriasis receiving systemic biologic...

    Robert R. McLean, Adam P. Sima, ... April Armstrong in Dermatology and Therapy
    Article Open access 27 September 2023
  20. Rapid Remission of Sunburn-Induced Guttate Psoriasis with Guselkumab

    Guselkumab is an anti-interleukin-23 monoclonal antibody that is approved for plaque psoriasis and psoriatic arthritis. We present a case of a...

    Erin Bartholomew, Bo-Young Chung, ... Wilson Liao in Dermatology and Therapy
    Article Open access 07 September 2023
Did you find what you were looking for? Share feedback.